Retroperitoneal ganglioneuroblastoma resected 8 years after mass screening: a case report.
An 8-year-old girl presented with abdominal tumor that was discovered incidentally. At surgery, the tumor originated from the retroperitoneal sympathetic trunk; and the histologic diagnosis was ganglioneuroblastoma, nodular (GNBn), unfavorable histology on Shimada's classification, International Neuroblastoma Staging System (INSS) stage 1. This patient was found positive for neuroblastoma (NB) by mass screening at 6 months old. There was no tumor detected, and tumor markers decreased to normal range by 18 months of age. We examined her previous computed tomographic films retrospectively and noticed a mass in the same region indicating that the tumor had been there for 8 years without treatment. This is the first report of infantile mass screening-positive NB appearing after long-term follow-up with unfavorable histology. And the follow-up interval was the longest ever reported. This case is suggestive of considering the natural history and treatment strategies for infantile NBs, and the relationship between infantile NB and ganglioneuroblastoma, nodular. It is important to follow mass screening-positive cases of NB over the long term if wait-and-see policy is adopted.
Nakaoka
Tatsuo
T
Department of Pediatric Surgery, Kawasaki Medical School, Kurasiki City, Okayama 701-0192, Japan. tnakaoka@med.kawasaki-m.ac.jp
Uemura
Sadashige
S
Nakagawa
Yoshikiyo
Y
Yano
Tsunehiro
T
Oda
Megumi
M
D014408:Biomarkers, Tumor / Q000097:blood*; D001707:Biopsy, Needle; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D018305:Ganglioneuroblastoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D006801:Humans; D007150:Immunohistochemistry; D007813:Laparotomy / Q000379:methods; D008279:Magnetic Resonance Imaging; D008403:Mass Screening; D019370:Observation; D012186:Retroperitoneal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D018570:Risk Assessment; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D014408:Biomarkers, Tumor